デフォルト表紙
市場調査レポート
商品コード
1787226

神経認知評価とリハビリテーションの世界市場

Neurocognitive Assessment and Rehabilitation


出版日
ページ情報
英文 269 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.69円
神経認知評価とリハビリテーションの世界市場
出版日: 2025年08月08日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 269 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

神経認知評価とリハビリテーションの世界市場は2030年までに217億米ドルに到達

2024年に146億米ドルと推定される神経認知評価とリハビリテーションの世界市場は、分析期間2024-2030年にCAGR 6.9%で成長し、2030年には217億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである神経リハビリテーション療法は、CAGR 5.6%を記録し、分析期間終了時には125億米ドルに達すると予測されます。神経認知評価検査分野の成長率は、分析期間中CAGR 8.9%と推定されます。

米国市場は40億米ドルと推定、中国はCAGR10.5%で成長予測

米国の神経認知評価とリハビリテーション市場は、2024年に40億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに45億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは10.5%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.5%と6.6%と予測されています。欧州では、ドイツがCAGR 4.5%で成長すると予測されています。

世界の神経認知評価とリハビリテーション市場- 主要動向と促進要因まとめ

神経認知アセスメントが現代ヘルスケアの重要な要素になりつつあるのはなぜか?

神経認知評価は、さまざまな年齢層や病状における認知機能障害を診断、モニタリング、管理するための重要なツールとして、急速に重要性を増しています。これらの評価は、記憶、注意、実行機能、言語、処理速度などの認知機能を評価するもので、ヘルスケア提供者が早期に神経障害を特定するのに役立っています。アルツハイマー病、パーキンソン病、外傷性脳損傷(TBI)、脳卒中、ADHDや自閉症などの神経発達障害といった疾患の有病率が上昇する中、神経認知検査は臨床や研究の場で不可欠なものとなっています。紙ベースの認知テストや構造化された臨床面接を含む従来の評価方法は、客観的でデータ駆動型の洞察を提供するデジタルツールによってますます補完されつつあります。また、機能的MRI(fMRI)、陽電子放射断層撮影(PET)、脳波(EEG)などの高度な神経画像技術も認知評価に組み込まれ、脳機能をより深く理解できるようになっています。さらに、神経認知検査に人工知能(AI)や機械学習を採用することで、従来の方法では検出できないような微妙な認知機能の変化を特定し、診断精度を高めています。遠隔医療とモバイルヘルス(mヘルス)アプリケーションは、医療施設を直接訪れることができない患者のための遠隔認知スクリーニングを可能にし、アクセシビリティをさらに促進しています。世界の人口が高齢化し、神経変性疾患の負担が増大し続ける中、効率的で正確かつスケーラブルな神経認知評価ソリューションへの需要が高まり、認知ヘルスケアの未来が再構築されると予想されます。

神経認知リハビリテーションにおける主な課題とは?

大きな進歩にもかかわらず、神経認知リハビリテーションは、その有効性と普及に影響を与える数多くの課題に直面しています。主な懸念事項の1つは、リハビリテーション介入に対する患者の反応のばらつきです。なぜなら、認知機能の回復は非常に個人差が大きく、障害の重症度、基礎疾患、治療計画の遵守などの要因に左右されるからです。さらに、特に神経ケアのインフラが限られている中低所得国では、専門的なリハビリテーションサービスへのアクセスが依然として大きな問題となっています。多くのヘルスケアシステムは、訓練を受けた神経心理学者、セラピスト、リハビリテーション専門家の不足に悩まされており、認知障害のある人に対する治療の遅れや最適とはいえない治療につながっています。もう1つの重大な課題は、神経認知リハビリテーションのための標準化されたプロトコルがないことです。医療提供者によって治療アプローチが異なるため、研究や臨床の場で結果を比較することが困難です。さらに、認知療法セッション、支援技術、在宅リハビリテーションツールなど、神経リハビリテーションプログラムの高額な費用は、多くの患者にとって障壁となりうる。認知リハビリテーションの保険適用範囲は地域によって異なり、長期の神経リハビリテーション療法に対する保険償還を除外または制限している政策もあります。さらに、認知リハビリは持続的な努力を必要とするため、記憶障害、疲労、注意力の低下などを経験した患者にとっては困難です。これらの課題に対処するには、神経リハビリテーション研究への投資拡大、ケアへのアクセスの改善、多様な患者のニーズに応える革新的で費用対効果の高いソリューションの開発など、多面的なアプローチが必要です。

技術の進歩はどのように神経認知リハビリテーションを変えていくのか?

認知療法の有効性、効率性、利用しやすさを高める技術革新によって、神経認知リハビリテーションの状況は大きく変わりつつあります。最もインパクトのある進歩の1つは、認知リハビリテーションプログラムにおける仮想現実(VR)と拡張現実(AR)の統合であり、これにより患者は、現実世界の認知課題をシミュレートする没入型のインタラクティブなトレーニング演習に取り組むことができます。これらの技術は、脳損傷や神経変性疾患から回復した患者の記憶力、問題解決能力、意思決定能力を向上させ、非常に魅力的でパーソナライズされたリハビリテーション体験を提供します。また、ブレイン・コンピュータ・インターフェイス(BCI)やニューロフィードバック・システムの利用も画期的で、脳の活動をリアルタイムでモニタリングし、調節することで、認知機能に関連する神経経路を強化することができます。さらに、モバイル・ヘルス・アプリケーションとAI主導の認知トレーニング・プラットフォームは、在宅リハビリテーションに革命をもたらし、患者と臨床医の双方にリアルタイムの進捗追跡を提供しながら、継続的な認知機能への関与を促すゲーム化されたエクササイズを提供しています。ウェアラブルバイオセンサーやスマートデバイスは、治療戦略の個別化に役立つ生理学的データや認知データを収集することで、神経認知リハビリテーションをさらに強化しています。ビッグデータ解析の台頭も重要な役割を果たしており、リハビリテーションの進捗状況を評価し、それに応じて介入を調整する予測モデルの開発を可能にしています。このような技術革新が進化し続けるにつれて、神経認知リハビリテーションはよりダイナミックに、患者中心で、個々のニーズに適応できるようになり、長期的な認知回復の成果の向上につながります。

神経認知評価とリハビリテーション市場の成長の原動力は?

神経認知評価とリハビリテーション市場の成長は、神経疾患の有病率の増加、デジタルヘルス技術の進歩、個別化された認知リハビリテーションソリューションに対する需要の高まりなど、いくつかの要因によって牽引されています。アルツハイマー病やパーキンソン病などの神経変性疾患の世界の増加は、高齢化社会と相まって、早期の認知機能評価と長期的なリハビリテーション戦略の需要を促進しています。さらに、スポーツ選手、軍人、事故被害者における外傷性脳損傷(TBI)の影響に対する認識の高まりが、高度な認知リハビリテーション・プログラムへの投資を加速させています。遠隔医療や遠隔ヘルスケアサービスの拡大も、神経認知評価ツールをより利用しやすくする上で極めて重要な役割を果たしており、患者は自宅に居ながらにして評価や治療セッションを受けることができます。AI主導の診断、デジタル認知トレーニング・プラットフォーム、ウェアラブル認知モニタリング・デバイスの採用が増加しており、臨床と自宅での認知ケアの両方に革新的なソリューションを提供することで、市場の成長をさらに促進しています。製薬業界も市場拡大に貢献しており、リハビリテーションの取り組みを補完することを目的とした神経保護薬や認知機能強化治療薬の研究が進んでいます。さらに、メンタルヘルスや認知ケアへの取り組みに対する規制当局の支援により、主要ヘルスケアへの神経認知評価の統合を促進する資金援助や償還政策が推進されています。データ主導のヘルスケアと個別化医療へのシフトは、個人の認知プロファイルと進行指標に基づいて治療計画を調整する精密神経リハビリテーションの機会も生み出しています。このような要因が神経認知評価とリハビリテーション市場を形成し続けているため、この業界は持続的な成長を遂げ、世界中の個人の認知的健康と生活の質を向上させる革新的なソリューションを提供すると予想されます。

セグメント

コンポーネントタイプ(神経リハビリテーション療法、神経認知評価テスト);プロバイダータイプ(リハビリセンター、病院&クリニック、在宅介護施設、理学療法センター)

調査対象企業の例

  • AnthroTronix Inc.
  • BioSensics
  • BrainCheck, Inc.
  • BrainScope Company, Inc.
  • Cambridge Cognition Holdings plc
  • CNS Vital Signs, LLC
  • Cogstate Ltd.
  • Constant Therapy Health
  • Encompass Health
  • Lumos Labs, Inc.(Lumosity)
  • MindMaze
  • NeuroCare Group
  • Neuroelectrics Corporation
  • NeuronUP SL
  • Neurotrack Technologies Inc.
  • Paradigm Healthcare
  • Posit Science Corporation
  • Qbtech AB
  • SCHUHFRIED GmbH
  • XRHealth

AIインテグレーション

私たちは、検証された専門家のコンテンツとAIツールで市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入(完成品とOEM)に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価(COGS)の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP32323

Global Neurocognitive Assessment and Rehabilitation Market to Reach US$21.7 Billion by 2030

The global market for Neurocognitive Assessment and Rehabilitation estimated at US$14.6 Billion in the year 2024, is expected to reach US$21.7 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Neurorehabilitation Therapy, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$12.5 Billion by the end of the analysis period. Growth in the Neurocognitive Assessment Testing segment is estimated at 8.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.0 Billion While China is Forecast to Grow at 10.5% CAGR

The Neurocognitive Assessment and Rehabilitation market in the U.S. is estimated at US$4.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.5 Billion by the year 2030 trailing a CAGR of 10.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Neurocognitive Assessment and Rehabilitation Market - Key Trends & Drivers Summarized

Why Is Neurocognitive Assessment Becoming a Crucial Component of Modern Healthcare?

Neurocognitive assessment is rapidly gaining importance as a critical tool for diagnosing, monitoring, and managing cognitive impairments across various age groups and medical conditions. These assessments evaluate cognitive functions such as memory, attention, executive function, language, and processing speed, helping healthcare providers identify neurological disorders at an early stage. With the rising prevalence of conditions like Alzheimer’s disease, Parkinson’s disease, traumatic brain injuries (TBI), stroke, and neurodevelopmental disorders such as ADHD and autism, neurocognitive testing has become indispensable in clinical and research settings. Traditional assessment methods, including paper-based cognitive tests and structured clinical interviews, are being increasingly supplemented by digital tools that offer objective and data-driven insights. Advanced neuroimaging techniques such as functional MRI (fMRI), positron emission tomography (PET), and electroencephalography (EEG) are also being integrated into cognitive assessments, providing a deeper understanding of brain function. Moreover, the adoption of artificial intelligence (AI) and machine learning in neurocognitive testing is enhancing diagnostic accuracy by identifying subtle cognitive changes that may be undetectable through conventional methods. Telemedicine and mobile health (mHealth) applications are further driving accessibility, allowing remote cognitive screening for patients who cannot visit healthcare facilities in person. As the global population ages and the burden of neurodegenerative diseases continues to grow, the demand for efficient, accurate, and scalable neurocognitive assessment solutions is expected to rise, reshaping the future of cognitive healthcare.

What Are the Key Challenges in Neurocognitive Rehabilitation?

Despite significant advancements, neurocognitive rehabilitation faces numerous challenges that impact its effectiveness and widespread adoption. One of the primary concerns is the variability in patient responses to rehabilitation interventions, as cognitive recovery is highly individualized and depends on factors such as the severity of impairment, underlying health conditions, and adherence to treatment plans. Additionally, access to specialized rehabilitation services remains a major issue, particularly in low- and middle-income countries where neurological care infrastructure is limited. Many healthcare systems struggle with a shortage of trained neuropsychologists, therapists, and rehabilitation specialists, leading to delayed or suboptimal treatment for individuals with cognitive impairments. Another critical challenge is the lack of standardized protocols for neurocognitive rehabilitation, as different healthcare providers may use varying therapeutic approaches, making it difficult to compare outcomes across studies and clinical settings. Furthermore, the high cost of neurorehabilitation programs, including cognitive therapy sessions, assistive technologies, and home-based rehabilitation tools, can be a barrier for many patients. Insurance coverage for cognitive rehabilitation varies across regions, with some policies excluding or limiting reimbursements for long-term neurorehabilitation therapies. Additionally, patient engagement and motivation remain significant hurdles, as cognitive rehabilitation requires sustained effort, which can be challenging for individuals experiencing memory deficits, fatigue, or reduced attention spans. Addressing these challenges requires a multi-faceted approach, including increased investment in neurorehabilitation research, improved accessibility to care, and the development of innovative, cost-effective solutions that cater to diverse patient needs.

How Are Technological Advancements Transforming Neurocognitive Rehabilitation?

The landscape of neurocognitive rehabilitation is undergoing a significant transformation, driven by technological innovations that enhance the effectiveness, efficiency, and accessibility of cognitive therapy. One of the most impactful advancements is the integration of virtual reality (VR) and augmented reality (AR) in cognitive rehabilitation programs, allowing patients to engage in immersive, interactive training exercises that simulate real-world cognitive challenges. These technologies provide a highly engaging and personalized rehabilitation experience, improving memory, problem-solving, and decision-making skills in patients recovering from brain injuries or neurodegenerative conditions. Another breakthrough is the use of brain-computer interfaces (BCIs) and neurofeedback systems, which enable real-time monitoring and modulation of brain activity, allowing individuals to strengthen neural pathways associated with cognitive function. Additionally, mobile health applications and AI-driven cognitive training platforms are revolutionizing home-based rehabilitation, offering gamified exercises that encourage continuous cognitive engagement while providing real-time progress tracking for both patients and clinicians. Wearable biosensors and smart devices are further enhancing neurocognitive rehabilitation by collecting physiological and cognitive data that help personalize treatment strategies. The rise of big data analytics is also playing a crucial role, enabling the development of predictive models that assess rehabilitation progress and adjust interventions accordingly. As these technological innovations continue to evolve, neurocognitive rehabilitation is becoming more dynamic, patient-centered, and adaptable to individual needs, leading to improved long-term cognitive recovery outcomes.

What Is Driving the Growth of the Neurocognitive Assessment and Rehabilitation Market?

The growth in the neurocognitive assessment and rehabilitation market is driven by several factors, including the increasing prevalence of neurological disorders, advancements in digital health technologies, and the rising demand for personalized cognitive rehabilitation solutions. The global rise in neurodegenerative diseases such as Alzheimer’s and Parkinson’s, coupled with an aging population, is fueling the demand for early cognitive assessments and long-term rehabilitation strategies. Additionally, the growing awareness of the impact of traumatic brain injuries (TBI) in athletes, military personnel, and accident victims has accelerated investments in advanced cognitive rehabilitation programs. The expansion of telemedicine and remote healthcare services has also played a pivotal role in making neurocognitive assessment tools more accessible, allowing patients to receive evaluations and therapy sessions from the comfort of their homes. The increasing adoption of AI-driven diagnostics, digital cognitive training platforms, and wearable cognitive monitoring devices is further enhancing market growth, providing innovative solutions for both clinical and at-home cognitive care. The pharmaceutical industry is also contributing to market expansion, with ongoing research into neuroprotective drugs and cognitive-enhancing therapeutics aimed at complementing rehabilitation efforts. Moreover, regulatory support for mental health and cognitive care initiatives is driving funding and reimbursement policies that promote the integration of neurocognitive assessment into mainstream healthcare. The shift toward data-driven healthcare and personalized medicine is also creating opportunities for precision neurorehabilitation, where treatment plans are tailored based on individual cognitive profiles and progress metrics. As these factors continue to shape the neurocognitive assessment and rehabilitation market, the industry is expected to witness sustained growth, offering transformative solutions that improve cognitive health and quality of life for individuals worldwide.

SCOPE OF STUDY:

The report analyzes the Neurocognitive Assessment and Rehabilitation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component Type (Neurorehabilitation Therapy, Neurocognitive Assessment Testing); Providers Type (Rehab Centers, Hospital & Clinics, Homecare Settings, Physiotherapy Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • AnthroTronix Inc.
  • BioSensics
  • BrainCheck, Inc.
  • BrainScope Company, Inc.
  • Cambridge Cognition Holdings plc
  • CNS Vital Signs, LLC
  • Cogstate Ltd.
  • Constant Therapy Health
  • Encompass Health
  • Lumos Labs, Inc. (Lumosity)
  • MindMaze
  • NeuroCare Group
  • Neuroelectrics Corporation
  • NeuronUP SL
  • Neurotrack Technologies Inc.
  • Paradigm Healthcare
  • Posit Science Corporation
  • Qbtech AB
  • SCHUHFRIED GmbH
  • XRHealth

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Neurocognitive Assessment and Rehabilitation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Neurological Disorders Propels Demand for Neurocognitive Assessment Tools
    • Aging Global Population Base Expands Addressable Market Opportunity for Cognitive Rehabilitation Solutions
    • Advancements in Brain-Computer Interface (BCI) Technology Strengthen Business Case for AI-Powered Neurotherapy
    • Integration of Digital Therapeutics and Gamification Drives Patient Engagement and Adoption Rates
    • Shift Toward Remote and Home-Based Healthcare Delivery Models Accelerates Demand for Portable Cognitive Assessment Devices
    • Growing Emphasis on Early Diagnosis of Dementia and Alzheimer's Drives Adoption of Screening Technologies
    • Increasing Use of Wearable Neuro-Monitoring Devices Spurs Growth in Real-Time Cognitive Tracking
    • Rising Investments in Neuroscience Research and Innovation Propels Development of Next-Gen Assessment Platforms
    • Favorable Reimbursement Policies in Developed Markets Sustain Growth Momentum for Cognitive Rehab Services
    • Regulatory Push for Standardization of Neurocognitive Testing Protocols Drives Market Formalization and Expansion
    • Convergence of Neuroimaging and Cognitive Analytics Expands Diagnostic and Rehabilitation Capabilities
    • Growing Application of AI and Machine Learning in Personalized Cognitive Rehabilitation Enhances Market Attractiveness
    • Emergence of VR and AR-Based Cognitive Therapy Solutions Generates High-Value Opportunities for Tech Innovators
    • Rising Adoption of Mental Health and Cognitive Wellness Programs in Corporate Settings Drives Market Penetration
    • Expanding Role of Cognitive Biomarkers in Clinical Trials Bolsters Demand for Digital Cognitive Assessment Tools
    • High Prevalence of Traumatic Brain Injuries Among Military and Sports Personnel Drives Demand for Targeted Rehabilitation Solutions
    • Integration of Cognitive Assessments in Primary Care Settings Broadens Market Reach and Accessibility
    • Public Awareness Campaigns on Cognitive Health and Aging Throw the Spotlight on Preventive Assessment Solutions
    • Rising Demand for Pediatric Cognitive Assessment Tools Driven by Growing Focus on Early Childhood Development
    • Cross-Industry Collaborations Between MedTech, Pharma, and Digital Health Players Accelerate Innovation Cycles
    • Data Privacy and Ethical Concerns Around Neurodata Collection Pose Regulatory Challenges and Impact Market Dynamics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neurocognitive Assessment and Rehabilitation Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neurocognitive Assessment and Rehabilitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Neurorehabilitation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Neurorehabilitation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Neurorehabilitation Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Neurocognitive Assessment Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Neurocognitive Assessment Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Neurocognitive Assessment Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Rehab Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Rehab Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Rehab Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospital & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospital & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Hospital & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Homecare Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Homecare Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Homecare Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Physiotherapy Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Physiotherapy Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Physiotherapy Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Neurocognitive Assessment and Rehabilitation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Neurocognitive Assessment and Rehabilitation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • INDIA
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Neurocognitive Assessment and Rehabilitation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Neurocognitive Assessment and Rehabilitation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • AFRICA
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030

IV. COMPETITION